Advanced search
Publication Cover
Leukemia & Lymphoma Volume 45, 2004 - Issue 1
Submit an article Journal homepage
138
Views
37
CrossRef citations to date
0
Altmetric
Original Article

Prognostic Significance of Surface Markers Expressed in Multiple Myeloma: CD56 and Other Antigens

NAOHI SAHARA Internal Medicine III, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu-shi, 431-3192, JapanCorrespondence[email protected]
&
AKIHIRO TAKESHITA Laboratory Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu-shi, 431-3192, Japan
Pages 61-65 | Received 10 May 2003, Published online: 03 Aug 2009

Citations (37)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Nadia ElMenshawy, Nora A. Farag, Doaa M. Atia, Nashwa Abousamra, Doaa Shahin, Eman Fawzi, Hayam Ghazi, Attalla F. El-kott & Mohamed Eissa. (2021) Prognostic Relevance of Concordant Expression CD69 and CD56 in Response to Bortezomib Combination Therapy in Multiple Myeloma Patients. Cancer Investigation 39:9, pages 777-782.
Read now
Tina Damgaard, Lene M. Knudsen, Inger Marie S. Dahl, Peter Gimsing, Marianne Lodahl & Thomas Rasmussen. (2009) Regulation of the CD56 promoter and its association with proliferation, anti-apoptosis and clinical factors in multiple myeloma. Leukemia & Lymphoma 50:2, pages 236-246.
Read now
Maria Kraj, Urszula Sokołowska, Joanna Kopeć-Szlęzak, Ryszard Pogłód, Barbara Kruk, Jolanta Woźniak & Tomasz Szpila. (2008) Clinicopathological correlates of plasma cell CD56 (NCAM) expression in multiple myeloma. Leukemia & Lymphoma 49:2, pages 298-305.
Read now

Articles from other publishers (34)

Laura Notarfranchi, Roberta Segreto, Rosanna Vescovini, Anna Benedetta Dalla Palma, Valentina Marchica, Jessica Burroughs‐Garcia, Denise Toscani, Giannalisa Todaro, Vincenzo Raimondi, Nicolas Thomas Iannozzi, Sabrina Bonomini, Gabriella Sammarelli, Luisa Craviotto, Mario Pedrazzoni, Paola Storti & Nicola Giuliani. (2022) The impact of CD56 expression in smoldering myeloma patients on early progression. Hematological Oncology 41:3, pages 587-589.
Crossref
Koichi Koizumi, Taishi Sakaue, Youji Nakase, Fumitaka Obayashi, Toshinori Ando, Tomoaki Shintani & Souichi Yanamoto. (2023) A case of multiple myeloma diagnosed by extramedullary disease in the submandibular region. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology 35:3, pages 247-250.
Crossref
Chuanying Geng, Huixing Zhou, Huijuan Wang, Yanchen Li, Yun Leng, Zhiyao Zhang, Yuan Jian, Guangzhong Yang & Wenming Chen. (2022) Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation. BMC Cancer 22:1.
Crossref
Epameinondas Koumpis, Iliana Tassi, Theodora Malea, Konstantina Papathanasiou, Ioannis Papakonstantinou, Anastasia Serpanou, Evangelos Tsolas, Eleni Kapsali, Theodoros P. Vassilakopoulos, Alexandra Papoudou-Bai & Eleftheria Hatzimichael. (2021) CD56 expression in multiple myeloma: Correlation with poor prognostic markers but no effect on outcome. Pathology - Research and Practice 225, pages 153567.
Crossref
Mesut Göçer & Erdal Kurtoğlu. (2020) Is absence of CD56 a predictive factor for peripheral blood stem cell mobilization failure in patients with multiple myeloma? . Journal of Clinical Apheresis 36:3, pages 332-339.
Crossref
Claudio Ortolani. 2021. Flow Cytometry of Hematological Malignancies. Flow Cytometry of Hematological Malignancies 301 427 .
Jina BhattacharyyaDr.Dr. & Gabyanjali DeviDr.Dr.. (2021) CLINICOPATHOLOGICAL STUDY OF MULTIPLE MYELOMA WITH EXPRESSION OF CD56. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH, pages 2-3.
Crossref
Takashi Yoshida, Masaki Ri, Shiori Kinoshita, Tomoko Narita, Haruhito Totani, Reham Ashour, Asahi Ito, Shigeru Kusumoto, Takashi Ishida, Hirokazu Komatsu & Shinsuke Iida. (2018) Low expression of neural cell adhesion molecule, CD56, is associated with low efficacy of bortezomib plus dexamethasone therapy in multiple myeloma. PLOS ONE 13:5, pages e0196780.
Crossref
Kah Teong Soh, Joseph D. TarioJr.Jr. & Paul K. Wallace. (2017) Diagnosis of Plasma Cell Dyscrasias and Monitoring of Minimal Residual Disease by Multiparametric Flow Cytometry. Clinics in Laboratory Medicine 37:4, pages 821-853.
Crossref
V. Innao, A. Allegra, S. Russo, D. Gerace, D. Vaddinelli, A. Alonci, A.G. Allegra & C. Musolino. (2017) Standardisation of minimal residual disease in multiple myeloma. European Journal of Cancer Care 26:6, pages e12732.
Crossref
Noriyoshi Iriyama, Katsuhiro Miura, Yoshihiro Hatta, Sumiko Kobayashi, Yoshihito Uchino, Daisuke Kurita, Hitomi Sakagami, Hiromichi Takahashi, Masashi Sakagami, Yujin Kobayashi, Masaru Nakagawa, Shimon Ohtake, Yoshikazu Iizuka & Masami Takei. (2017) Clinical effect of immunophenotyping on the prognosis of multiple myeloma patients treated with bortezomib. Oncology Letters 13:5, pages 3803-3808.
Crossref
PENGJUN JIANG, WEN XIA, XUEMEI SUN, XINGBIN DAI & LIN LI. (2016) Small-lymphoid cells and myeloid antigen expression in a patient with IgG myeloma: A case report. Oncology Letters 11:3, pages 2152-2154.
Crossref
Haruo Hirakawa, Yasuyuki Nishi, Taisuke Watanabe, Makoto Tada & Atsushi Sasaki. (2014) A Case of Laryngo-tracheal Involvement of Multiple Myelomas. Practica oto-rhino-laryngologica. Suppl. 138:0, pages 88-89.
Crossref
Eli Muchtar, Pia Raanani, Moshe Yeshurun, Ofer Shpilberg & Hila Magen-Nativ. (2014) Myeloma in Scar Tissue - An Underreported Phenomenon or an Emerging Entity in the Novel Agents' Era? A Single Center Series. Acta Haematologica 132:1, pages 39-44.
Crossref
Bruno PaivaTeresa Paino, Jose-Maria Sayagues, Mercedes Garayoa, Laura San-Segundo, Montserrat Martín, Ines Mota, María-Luz Sanchez, Paloma Bárcena, Irene Aires-Mejia, Luis Corchete, Cristina Jimenez, Ramon Garcia-Sanz, Norma C. Gutierrez, Enrique M. Ocio, Maria-Victoria Mateos, Maria-Belen Vidriales, Alberto Orfao & Jesús F. San Miguel. (2013) Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile. Blood 122:22, pages 3591-3598.
Crossref
Martin F. Kaiser, David C. JohnsonPing WuBrian A. WalkerAnnamaria Brioli, Fabio MirabellaChristopher P. WardellLorenzo MelchorFaith E. DaviesGareth J. Morgan. (2013) Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma. Blood 122:2, pages 219-226.
Crossref
Mike Leach, Mark Drummond & Allyson Doig. 2013. Practical Flow Cytometry in Haematology Diagnosis. Practical Flow Cytometry in Haematology Diagnosis 173 183 .
Haruo Hirakawa, Yasuyuki Nishi, Taisuke Watanabe, Makoto Tada & Atsushi Sasaki. (2013) A Case of Laryngo-tracheal Involvement of Multiple Myelomas. Practica Oto-Rhino-Laryngologica 106:12, pages 1095-1103.
Crossref
Jesús F. San-Miguel, Ramón García-Sanz & Norma C. Gutiérrez. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 615 636 .
Anja Seifert, Dagobert Glanz, Nicole Glaubitz, Rüdiger Horstkorte & Kaya Bork. (2012) Polysialylation of the neural cell adhesion molecule: Interfering with polysialylation and migration in neuroblastoma cells. Archives of Biochemistry and Biophysics 524:1, pages 56-63.
Crossref
Anna Tasidou, Maria Roussou, Evangelos Terpos, Efstathios Kastritis, Maria Gkotzamanidou, Maria Gavriatopoulou, Magdalini Migkou, Evangelos Eleutherakis‐Papaiakovou, Nikitas Nikitas, Dimitra Anagnostou & Meletios A. Dimopoulos. (2012) Increased expression of cyclin‐D1 on trephine bone marrow biopsies independently predicts for shorter overall survival in patients with multiple myeloma treated with novel agents. American Journal of Hematology 87:7, pages 734-736.
Crossref
Claudio Ortolani. 2011. Flow Cytometry of Hematological Malignancies. Flow Cytometry of Hematological Malignancies 160 300 .
Claudio Ortolani. 2011. Flow Cytometry of Hematological Malignancies. Flow Cytometry of Hematological Malignancies 1 157 .
Hans E. Johnsen, Martin Bøgsted, Tobias W. Klausen, Peter Gimsing, Alexander Schmitz, Erik Kjærsgaard, Tina Damgaard, Pia Voss, Lene M. Knudsen, Anne K. Mylin, Johan Lanng Nielsen, Bo Björkstrand, Astrid Gruber, Stig Lenhoff, Kari Remes, Inger Marie Dahl, Kirsten Fogd & Karen Dybkær. (2010) Multiparametric flow cytometry profiling of neoplastic plasma cells in multiple myeloma. Cytometry Part B: Clinical Cytometry 78B:5, pages 338-347.
Crossref
Bruno Paiva, Julia Almeida, Martin Pérez‐Andrés, Gema Mateo, Antonio López, Ana Rasillo, María‐Belén Vídriales, María‐Consuelo López‐Berges, Jesús F. San Miguel & Alberto Orfao. (2010) Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell‐related disorders. Cytometry Part B: Clinical Cytometry 78B:4, pages 239-252.
Crossref
Silvia Zecchini & Ugo Cavallaro. 2010. Structure and Function of the Neural Cell Adhesion Molecule NCAM. Structure and Function of the Neural Cell Adhesion Molecule NCAM 319 333 .
Jan A. BurgerPaolo Ghia, Andreas Rosenwald & Federico Caligaris-Cappio. (2009) The microenvironment in mature B-cell malignancies: a target for new treatment strategies. Blood 114:16, pages 3367-3375.
Crossref
Maria G. Ioannou, Efstathios Stathakis, Andreas C. Lazaris, Thomas Papathomas, Evangelos Tsiambas & George K. Koukoulis. (2008) Immunohistochemical Evaluation of 95 Bone Marrow Reactive Plasmacytoses. Pathology & Oncology Research 15:1, pages 25-29.
Crossref
Gema Mateo, M. Angeles Montalbán, Maria-Belén Vidriales, Juan J. Lahuerta, Maria V. Mateos, Norma Gutiérrez, Laura Rosiñol, Laura Montejano, Joan Bladé, Rafael Martínez, Javier de la Rubia, Joaquín Diaz-Mediavilla, Anna Sureda, José M. Ribera, José M. Ojanguren, Felipe de Arriba, Luis Palomera, Maria J. Terol, Alberto Orfao & Jesús F. San Miguel. (2008) Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy. Journal of Clinical Oncology 26:16, pages 2737-2744.
Crossref
Fiona E. Craig & Kenneth A. Foon. (2008) Flow cytometric immunophenotyping for hematologic neoplasms. Blood 111:8, pages 3941-3967.
Crossref
Rafael Fonseca & Jesus San Miguel. (2007) Prognostic Factors and Staging in Multiple Myeloma. Hematology/Oncology Clinics of North America 21:6, pages 1115-1140.
Crossref
Jesús F. San Miguel, Ramón García-Sanz & Norma C. Gutiérrez. 2007. Multiple Myeloma: Translational and Emerging Therapies. Multiple Myeloma: Translational and Emerging Therapies 115 140 .
Yoshiaki Kuroda, Akira Sakai, Yoshiko Okikawa, Shoso Munemasa, Yuta Katayama, Hideo Hyodo, Jun Imagawa, Yasuo Takimoto, Hajime Okita, Megu Ohtaki & Akiro Kimura. (2005) The Maturation of Myeloma Cells Correlates with Sensitivity to Chemotherapeutic Agents. International Journal of Hematology 81:4, pages 335-341.
Crossref
. (2004) Current Awareness in Hematological Oncology. Hematological Oncology 22:2, pages 73-84.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.